OBJECTIVE: To assess long-term survival and health-related quality of life in patients with acute renal failure. DESIGN AND SETTING: Cross-sectional cohort study in the ten-bed medical-surgical intensive care unit and the three-bed acute dialysis unit in a tertiary care hospital. PATIENTS: 703 patients receiving renal replacement therapy for acute renal failure during 1998-2002. MEASUREMENTS AND RESULTS: The mortality rate was 41% at 28 days, 57% at 1 year, and 70% at 5 years. SOFA score, age, and continuous renal replacement therapy were independent predictors of 1-year mortality. The median follow-up time was 3.9 years for mortality and 2.4 years for health-related quality of life. Of the 229 survivors in 2003, 153 (67%) responded to the health-related quality of life questionnaire. Health-related quality of life was evaluated with the EuroQol (EQ-5D) instrument including a visual analogue scale (VAS) score to evaluate the patient's perceived health. The EQ-5D score was significantly lower in the study population than in the age- and gender-matched Finnish population (0.68 vs. 0.86). Median VAS scores were 69.5 and 70.0, respectively. Patients' age and duration of follow-up had no significant effect on EQ-5D or VAS scores. Mortality and EQ-5D data were used to calculate quality-adjusted life years. Quality-adjusted survival was poor (15 quality-adjusted life years per 100 patients in the first year of follow-up). CONCLUSIONS: The long-term survival of patients with acute renal failure is poor. Although survivors have a low health-related quality of life, they are as satisfied with their health as the general population.
OBJECTIVE: To assess long-term survival and health-related quality of life in patients with acute renal failure. DESIGN AND SETTING: Cross-sectional cohort study in the ten-bed medical-surgical intensive care unit and the three-bed acute dialysis unit in a tertiary care hospital. PATIENTS: 703 patients receiving renal replacement therapy for acute renal failure during 1998-2002. MEASUREMENTS AND RESULTS: The mortality rate was 41% at 28 days, 57% at 1 year, and 70% at 5 years. SOFA score, age, and continuous renal replacement therapy were independent predictors of 1-year mortality. The median follow-up time was 3.9 years for mortality and 2.4 years for health-related quality of life. Of the 229 survivors in 2003, 153 (67%) responded to the health-related quality of life questionnaire. Health-related quality of life was evaluated with the EuroQol (EQ-5D) instrument including a visual analogue scale (VAS) score to evaluate the patient's perceived health. The EQ-5D score was significantly lower in the study population than in the age- and gender-matched Finnish population (0.68 vs. 0.86). Median VAS scores were 69.5 and 70.0, respectively. Patients' age and duration of follow-up had no significant effect on EQ-5D or VAS scores. Mortality and EQ-5D data were used to calculate quality-adjusted life years. Quality-adjusted survival was poor (15 quality-adjusted life years per 100 patients in the first year of follow-up). CONCLUSIONS: The long-term survival of patients with acute renal failure is poor. Although survivors have a low health-related quality of life, they are as satisfied with their health as the general population.
Authors: T M Muniraju; M H Lillicrap; J L Horrocks; J M Fisher; R M W Clark; N S Kanagasundaram Journal: Clin Med (Lond) Date: 2012-06 Impact factor: 2.659
Authors: Kirsten L Johansen; Mark W Smith; Mark L Unruh; Andrew M Siroka; Theresa Z O'Connor; Paul M Palevsky Journal: Clin J Am Soc Nephrol Date: 2010-05-27 Impact factor: 8.237
Authors: Pierre-Marc Villeneuve; Edward G Clark; Lindsey Sikora; Manish M Sood; Sean M Bagshaw Journal: Intensive Care Med Date: 2015-12-01 Impact factor: 17.440
Authors: Vilija R Joyce; Mark W Smith; Kirsten L Johansen; Mark L Unruh; Andrew M Siroka; Theresa Z O'Connor; Paul M Palevsky Journal: Clin J Am Soc Nephrol Date: 2012-05-17 Impact factor: 8.237
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel de Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-01 Impact factor: 17.440
Authors: Peter Schenk; Joanna Warszawska; Valentin Fuhrmann; Franz König; Christian Madl; Klaus Ratheiser Journal: Wien Klin Wochenschr Date: 2012-08-09 Impact factor: 1.704